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Received January 29, 2014; accepted February 17, 2014AbstractBackground: A recent research breakthrough has demonstrated that the ectopic expression of four genes is sufficient to reprogram human fi-
broblasts into inducible pluripotent stem cells (iPSCs). However, whether human dental pulp cells (DPCs) could be reprogrammed into iPSCs
remains an open question. In this study, we demonstrated that DPCs from deciduous and permanent teeth can be reprogrammed into iPSCs
without c-Myc and had the capacity to differentiate into neuron-like cells.
Methods: DPCs were obtained from donors and reprogrammed into iPSCs using retroviral transduction with SOX2, OCT4, and KLF4. Then,
these iPSCs were differentiated into neuron-like cells. Microarray and bioinformatics were used to compare the gene expression profile among
these iPSCs and iPSC-derived neuron-like cells.
Results: The DPCs displayed a high vitality and capability to quickly restart proliferation and expressed elevated pluripotency similar to
mesenchymal stem cells. According to our results, DPC-derived iPSC colonies that could be subcultured and propagated were established as
early as 10 days after transduction, in comparison with the skin fibroblast (DPC-derived iPSCs) without c-Myc presented embryonic stem cell-
like properties and the pluripotent potential to differentiate into neuron-like cells, which resemble neurons both morphologically and
functionally.
Conclusion: The human DPCs from deciduous and permanent teeth can undergo reprogramming to establish pluripotent stem cell lines without
c-Myc. These surgical residues, usually regarded as medical waste, can be used as an alternative source of pluripotent stem cells for personalized
medicine.
Copyright © 2014 Elsevier Taiwan LLC and the Chinese Medical Association. All rights reserved.
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Induced pluripotent stem cells (iPSCs) are novel stem-cell
populations induced from adult somatic cells through
reprogramming by transduction of defined transcription fac-
tors.1,2 Cumulative evidence has shown that iPSCs are indis-
tinguishable from embryonic stem cells (ESCs) in terms ofociation. All rights reserved.
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renewal and differentiation into three germ layers.1,3 Thus,
iPSCs offer a means to study disease-specific cells from living
patients, and serve as a bridge between clinical and bench
research.4 Furthermore, these patient-specific iPSCs bearing
specific mutations have great potential for modeling disease
phenotypes, screening candidate drugs, and cell replacement
therapy provided that the underlying disease-causing mutation
can be corrected.5,6 To date, iPSCs have been derived from
many different species, such as humans, rhesus monkeys,
mice, rats, marmosets, pigs, and rabbits. The cell types that
have been successfully reprogrammed include hepatocytes,
gastric epithelial cells, keratinocytes, stomach cells, mesen-
chymal cells, neural stem cells (NSCs), pancreatic cells, B and
T lymphocytes, cord blood cells, and peripheral blood cells,
among others. Generally, human iPSCs are normally derived
from dermal fibroblasts because of their accessibility and
relatively high reprogramming efficiency. However, prior to
using dermal fibroblasts, skin biopsy and a prolonged period
of cell culture expansion are required. During the skin biopsy,
the exposure of the dermis to ultraviolet light might increase
the risk for chromosomal aberrations. In addition, patients
would experience pain and risk the possibility of infection
during the process of obtaining dermal fibroblasts. These is-
sues limit the wide application of iPSCs.
Dental pulp is a specific tissue originating from the cranial
neural crest and is enclosed into a dental cavity surrounded by
mineralized dentin. The dental pulp tissue can be isolated
from human exfoliated deciduous and permanent teeth, which
are usually regarded as medical waste.7 Because of its dif-
ferentiation potential and accessibility, interest in dental pulp
in regenerative medicine is gradually increasing.8,9 Previous
studies have shown that the dental pulp cells (DPCs),
including dental-pulp stem cells (DPSCs), express elevated
levels of pluripotent factors, resulting in significantly more
efficient and accelerated generation of iPSCs compared with
conventional somatic cells. The c-Myc oncogene may
contribute to tumorigenesis by overstimulating cell growth
and metabolism and/or by causing genomic instability.
Deregulated expression of c-Myc occurs in a wide range of
human cancers and is often associated with poor prognosis,
indicating that this oncogene plays a key role in tumor pro-
gression. The ability of in vivo teratoma formation has been
used as a landmark for evaluating the pluripotency of iPSCs.10
Previous studies have successfully generated iPSCs from
mouse and human fibroblasts using only three transcription
factors: OCT4/SOX2/KLF4 (without c-Myc), and mice
derived from these iPSCs without c-Myc did not develop tu-
mors during the study period.11,12 However, whether reprog-
ramming human DPCs from exfoliated deciduous and
permanent teeth into iPSCs in the absence of c-Myc can be
successfully generated and present the ability to differentiate
is still unclear.
In this study, we took advantage of the remarkable capacity
of the human DPCs, and reprogrammed the DPCs to establish
pluripotent stem-cell lines from exfoliated deciduous and
permanent teeth via retroviral transduction of OCT4, SOX2,and KLF4. After receiving proper differentiation stimuli, these
DPC-derived iPSCs (DPC-iPSCs) differentiated into func-
tional neuron-like cells that expressed various neuronal
markers. Our findings may provide an alternative cell source
and strategy for iPSCs without c-Myc-based personalized
therapies for human disease.
2. Methods2.1. Isolation of human DPCsTeeth were obtained from one child undergoing deciduous
tooth extraction and two adult donors undergoing third molar
extraction. All patients provided informed consent according
to the guidelines of the Ethical Committee of the Taipei Vet-
erans General Hospital (IRB No. 2012-08-009A). The
extraction procedure was performed under standard conditions
for local anesthesia. The extracted teeth were treated with
disinfecting solution anddtogether with the pulpd-
transported in Hank's balanced salt solution (Invitrogen,
Carlsbad, CA, USA) to the tissue cultures laboratory.
Extracted dental pulp tissue was then enzymatically treated
with 3 mg/mL collagenase type I and 4 mg/mL dispase to
completely digest the pulp tissue. After centrifugation, the cell
pellet was obtained and the supernatant aspirated. Human
DPCs were maintained in Dulbeccos's modified Eagle's me-
dium (DMEM) supplemented with 20% fetal bovine serum,
nonessential amino acid, L-glutamine and penicillin/strepto-
mycin at 37C with 5% CO2.2.2. Human iPSC generation and cultureiPSCs were reprogrammed via the transduction of pMXs
vectors encoding the transcription factors OCT4, SOX2, and
KLF4. The Plat-A cells used for plasmid transfection were
incubated overnight at a density of 2.5  106 cells/100-mm
dish. The next day, 10 mg of pMXs-containing cDNA was
transfected into the Plat-A cells with 10 mL of fresh DMEM
using TransIT-LT1 (Mirus, Madison, WI, USA). Forty-eight
hours after transfection, the virus-containing medium was
collected for target cell infection. In preparation for viral
infection, 5  104 target cells were seeded per well into six-
well plates 1 day prior to transduction. Supernatants con-
taining equal amounts of each of the four retroviruses were
filtered through a 0.45-mm filter and supplemented with
10 mg/mL polybrene (Sigma, St. Louis, MO, USA), and the
medium in the six-well plates was replaced with the virus-
containing medium. The six-well plates were centrifuged at
2250 rpm for 1 hour, and then the medium was replaced. At
Days 10e14 after infection, target cells were passaged onto
mitotically inactivated mouse embryonic fibroblast (MEF)
feeder layers and cultured using the human ESC medium. The
drugs SB431542 (2 mM), PD0325901 (0.5 mM; Stemgent),
and Thiazovivin (STEMCELL Technologies; Vancouver, BC,
Canada) (0.5 mM) were added to the culture medium to aid
colony formation. The drug-containing medium was replaced
daily until iPSC colonies were detected. Undifferentiated
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(50,000 cells/cm2) in human ESC medium [DMEM/F12;
Gibco (Grand Island, NY, USA)] supplemented with 20%
KnockOut serum replacement (KSR; Invitrogen), 0.1 mM
nonessential amino acids (Invitrogen), 1 mM L-glutamine,
0.1 mM b-mercaptoethanol, 10 ng/mL recombinant human
basic fibroblast growth factor, and antibiotics (Gibco). To
prevent MEF contamination, human iPSCs cells were trans-
ferred to a feeder-free/serum-free culture system in CSTI-8
medium (Cell Science & Technology Institute Inc., Sendai,
Japan) without KSR supplementation.2.3. In vitro differentiationFor in vitro differentiation, iPSCs were dispersed into small
clumps using dispase (Sigma-Aldrich, St. Louis, MO, USA;
1 mg/mL for 30 minutes) and transferred onto ultralow
attachment plates (Corning Inc., Corning, NY, USA) for
Embryoid Body (EB) formation. The medium was changed
daily for 3 days, and the medium used was the same type of
medium as that used for routine hESC culture. EBs were then
transferred onto 0.1% gelatin-coated culture dishes with the
fetal bovine serum-containing medium. The medium was
changed every 2 days for 20 days.2.4. Quantitative reverse transcription-polymerase chain
reactionSYBR green was used for real-time reverse transcription-
polymerase chain reaction (RT-PCR) detection. Briefly, total
RNA (1 mg) of each sample was reverse-transcribed in 20 mL
using 0.5 mg of oligo-dT and 200 U Superscript II RT (Invi-
trogen). Amplification was carried out in a total volume of
20 mL containing 0.5 mM of each primer, 4 mM MgCl2, 2 mL
LightCyclereFastStart DNA Master SYBR green I (Roche
Diagnostics GmbH, Mannheim, Germany), and 2 mL of 1:10
diluted cDNA. All reactions were performed in triplicate. The
transcript levels of genes were standardized to the corresponding
glyceraldehyde-3-phosphate dehydrogenase (GAPDH) level,
and for each candidate gene, mRNA levels relative to the highest
candidate gene level were estimated in percentages.2.5. Induced differentiation of DP-iPSCs into neuron-
like cellsThere were 1  105 iPSCs at the 5th to 8th passages that
were treated with a serum-free modified neurogenic selection
medium for 2 weeks. The serum-free medium for the selection
of neural precursor cells contained DMEM/F12 1:1 (Gibco
BRL) and was supplemented with 0.6% glucose, 25 mg/mL
insulin, 100 mg/mL transferrin, 20 nM progesterone, 60 mM
putrescine, 30 nM selenium chloride, 2 mM glutamine, 3 mM
sodium bicarbonate, 5 mM HEPES buffering agent, 2 mg/mL
heparin, 20 ng/mL Epidermal growth factor (EGF), and 20 ng/
mL basic fibroblast growth factor (all from Sigma). For further
neural differentiation, EGF was removed from the medium,
and the medium was supplemented with 20 ng/mL Sonichedgehog (SHH) (R&D), NY, USA, 10 ng/mL Brain-derived
neurotrophic factor (BDNF) (R&D), and all-trans retinoic acid
(100 nM) for another 7 days.132.6. ImmunofluorescenceThe living cells and spheres were fixed in 4% para-
formaldehyde, permeabilized in 0.1% Triton X-100, and
blocked in 5% normal goat serumephosphate buffered saline.
Cells were incubated with primary antibodies, washed three
times in phosphate buffered saline, and then incubated with
goat antimouse or secondary antibodies conjugated with
fluorescein isothiocyanate (green) or phycoerythrin (red).
DAPI (40,6-diamidino-2-phenylindole) was used as a nuclear
stain (blue). Images were obtained using fluorescent micro-
scopy and a digital camera. The antibodies that were used are
listed in Table S1.2.7. Microarray analysis and bioinformaticsTotal RNA was extracted from cells using Trizol reagent
(Life Technologies, Bethesda, MD, USA) and the Qiagen
RNeasy (Qiagen, Valencia, CA, USA) column for purification.
Total RNA was reverse-transcribed with Superscript II RNase
H-reverse transcriptase (Gibco BRL) to generate Cy3- and
Cy5-labeled (Amersham Biosciences Co., Piscataway, NJ,
USA) cDNA probes for the control and treated samples,
respectively. The labeled probes were hybridized to a cDNA
microarray containing 10,000 immoblized gene clone cDNA
fragments. Fluorescence intensities of Cy3 and Cy5 targets
were measured and scanned separately using a GenePix 4000B
Array Scanner (Axon Instruments, Burlingame, CA, USA).
Data analysis was performed using GenePix Pro 3.0.5.56
(Axon Instruments) and GeneSpring GX 7.3.1 software
(Agilent, Palo Alto, CA, USA). The average-linkage distance
was used to assess the similarity between two groups of gene
expression profiles as described below. The difference in dis-
tance between two groups of sample expression profiles to a
third was assessed by comparing the corresponding average-
linkage distances [the mean of all pairwise distances (link-
ages) between members of the two groups concerned]. The
error of such a comparison was estimated by combining the
standard errors (the standard deviation of pairwise linkages
divided by the square root of the number of linkages) of the
average-linkage distances involved. Classical multidimen-
sional scaling was performed using the standard function of
the R program to provide a visual impression of how the
various sample groups are related.2.8. Statistical analysisThe results are expressed as mean ± standard deviation.
Statistical analyses were performed using the Student t test for
comparing two groups, and one-way or two-way analysis of
variance followed by Bonferroni's test was used to detect
differences among three or more groups. Results were
considered statistically significant at p < 0.05.
Table 1
Clinical characteristics of patients.
Case no. Age
(y)
Phase Isolation of
DPC
Reprogramming
DPC-iPSCs
Case 1 23 Permanent teeth Successful Successful
Case 2 6 Deciduous teeth Successful Successful
Case 3 37 Permanent teeth Successful Successful
DPC ¼ dental pulp cell; DPC-iPSCs ¼ DPC-derived inducible pluripotent
stem cells.
621Y.-C. Chang et al. / Journal of the Chinese Medical Association 77 (2014) 618e6253. Results3.1. Isolation and characterization of DPCs from teethAs shown in Table 1, teeth were obtained from one child
undergoing deciduous tooth extraction (Case 2) and from two
adult donors undergoing third molar extraction (Cases 1 and
3). We separated the teeth from the crown using Luer forceps,
and we used sharp needles or excavators to release dental pulp
from the pulp chamber, after wide access was achieved
(Fig. 1A). A sparse number of DPCs attached to the culture
dish and the majority of cells displayed a fibroblast-like,Fig. 1. Isolation and characterization of dental pulp cells (DPCs). (A) Extracted den
expansion/selection medium, isolated DPCs were morphologically uniform and
Representative flow cytometer results of DPCs from permanent teeth on Day 14
molecules. Gate was defined considering the isotype control IgG-stained sample vspindle-shaped morphology during the early days of incuba-
tion (Fig. 1B, upper). After plating for 7e10 days, these pri-
mary cells reached 80% confluence during their 1st passage
(Fig. 1B, lower). Moreover, cells that were stored long term at
80C demonstrated high vitality and capability to quickly
restart proliferation. We used some markers to define our
cultured cells. Our data indicated that DPCs expressed CD44,
CD90, and CD105, but not CD34 and CD45. These findings
are consistent with the undifferentiated state of DPCs and are
similar to that of mesenchymal stem cells (MSCs) (Fig. 1C).3.2. Characterization of human DPC-iPSCsThe isolation and cultivation of DPSCs have been previ-
ously reported.14e16 However, it remains to be determined
whether DPCs from exfoliated deciduous teeth and permanent
teeth can provide alternative cell sources to be reprogrammed
into iPSCs. In the present study, we isolated DPCs from
human dental pulp and reprogrammed these cells into iPSCs
via transfection with retroviral vectors encoding the tran-
scription factors OCT4, SOX2, and KLF4. As the reprog-
ramming progressed, these cells gradually formed colonies oftal pulp tissue from exfoliated permanent teeth. (B) After 5 days and 10 days in
highly proliferative. Phase contrast microscopy; magnification,  200. (C)
after cell culturing with antibodies reactive to the stem cell-related surface
ersus specific antibody staining profile.
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feeder cells in KSR-based media and stained positive for
alkaline phosphate and exhibited a morphology indistin-
guishable from that of fibroblast-derived iPSCs and human
ESCs (Fig. 2A). The RT-PCR results showed that the 20th
DPC-iPSCs expressed the genes OCT4, SOX2, REX1, GDF3,
Nanog, KLF4, and DPPA2, all of which are also expressed in
the human ESCs (Fig. 2B). Immunofluorescence results indi-
cated that DPC-iPSCs from the 20th passage showed a strong
expression of Oct4, Nanog, SSEA4, Tra-1-81, and Tra-1-60
(Fig. 2C). Using differentiation protocols for tridermal line-
ages, the 20th DPC-iPSC-derived embryonic bodies could also
be induced to differentiate into neuron-like cells, smooth
muscle cells, and hepatocyte-like cells (ectoderm, mesoderm,
and endoderm). Immunofluorescence analysis demonstrated
the expression of markers specific to each lineage, i.e., Nestin,
SMA, and AFP, respectively (Fig. 2D). Taken together, our
data demonstrated that human DPCs can be reprogrammed,
and DPC-iPSCs present ESC-like properties and are capable
of multilineage differentiation.Fig. 2. Establishment and characterization of inducible pluripotent stem cells der
photomicrograph and alkaline phosphatase activity of DPC-iPSCs and fibroblast
chain reaction (RT-PCR) results indicated an embryonic stem cell (ESC)-like ge
used as a negative control, and human ES S6 cells were used as a positive control.
markers in undifferentiated DPC-iPSCs. Nuclei were counterstained with 40,6-dia
rescence staining demonstrated that markers for the three germ layers were expresse
(blue); magnification,  100. Data shown here are derived from permanent teeth,3.3. Differentiation of human dental pulp-derived iPSCs
into neural progenitor cellsThe protocol for differentiating iPSCs into neural pro-
genitors followed previously established methods, and both
the iPSCs and ESCs were separated from the feeder fibroblasts
prior to differentiation.17 Four weeks after the neural induc-
tion, DPC-iPSC-derived neurons formed extensive networks
and stained positively for Nestin and the mature neuronal
marker MAP2 (Fig. 3A). Using microarray analysis, we sub-
sequently compared the gene expression profile among hip-
pocampus, SH-SY5Y cell line (neuroblast from neural tissue),
ESC-derived neuron-like cells (ESC-Neus), and DPC-iPSC-
derived neuron-like cells (DPC-iPSC-Neus) (Fig. 3B). The
profile of differentially expressed genes of DPC-iPSC-Neus
was similar to those of ESC-Neus, hippocampus and SH-
SY5Y cell line, but different from those of NSCs, ESCs, or
DPC-iPSCs. Multidimensional scaling (Fig. 4A) and average
distance analysis (Fig. 4B) further showed that the gene
expression pattern of DPC-iPSC-Neus was closer to the geneived from dental pulp cells (DPC-iPSCs). (A) Representative phase-contrast
(FB)-iPSCs; magnification,  40. (B) The reverse transcription-polymerase
ne expression pattern in representative colonies of DPC-iPSCs. DPCs were
(C) Immunofluorescence staining demonstrated the expression of pluripotency
midino-2-phenylindole (DAPI; blue); magnification,  100. (D) Immunofluo-
d in spontaneously differentiated iPSCs. Nuclei were counterstained with DAPI
representatively.
Fig. 3. Differentiation of three-gene DPC-iPSCs into neural cells. (A) Immunofluorescence staining for neuronal marker Nestin and MAP2 demonstrated
morphology and neurons formed extensive networks in DPC-iPSC-Neus. Nuclei were counterstained with DAPI (blue); magnification,  200. (B) Gene expression
microarray analysis showing genes that were differentially expressed in DPC-iPSCs, ESCs, NSCs, hippocampus, neuroblast (SH-SY5Y), ESC-Neus, and DPC-
iPSC-Neus using a hierarchy heat map. Data shown here are derived from permanent teeth, representatively. DAPI ¼ 40,6-diamidino-2-phenylindole;
DPC ¼ dental pulp cell; DPC-iPSCs ¼ DPC-derived iPSCs; DPC-iPSC-Neus ¼ DPC-iPSC-derived neuron-like cells; ESCs ¼ embryonic stem cells; ESC-
Neus ¼ ESC-derived neuron-like cells; iPSCs ¼ inducible pluripotent stem cells; NSCs ¼ neural stem cells.
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iPSCs. Quantitative real-time RT-PCR analysis revealed that
the expression of neural-specific markers, including Nestin,
GFAP, MAP2, and NCAM1, were initially upregulated in
DPC-iPSC-Neus after the induction of neural differentiation
for 7 days, 14 days, and 21 days (Fig. 4C). The mRNA ex-
pressions of these neural-specific markers were statistically
increased during the course of differentiation. Taken together,
these data supported the view that DPC-iPSCs without c-Myc
present the pluripotent potential to differentiate into neuron-
like cells, which resemble neurons both morphologically and
functionally.
4. Discussion
DPSCs were first isolated by Gronthos and coworkers in
2000.14 They described the identification of DPSCs by virtue
of their clonogenic abilities, rapid proliferative rates, and ca-
pacity to form mineralized tissues both in vitro and in vivo.
Compared with other stem cells such as MSCs from the bone
marrow and NSCs from cadavers, DPSCs are more easily
isolated.18 There are several published data reporting the
successful isolation of a stem cell population from human
exfoliated deciduous teeth, third molars, or wisdom teeth.14e16In addition, extraction of DPSCs presents no loss to the in-
dividual and can be expanded with ease or stored without
detriment.19 This feature of DPSCs opens up the potential for
autologous transplantation and removes the need for immu-
nosuppressive therapy. However, preliminary studies have
shown that the stem cell or potential progenitor cell population
in dental pulp comprises <1% of the total cells.20,21 Histo-
morphometric analyses of pulpal cell populations imply that
age-related reductions in pulpal cell numbers occur.22 There-
fore, the efficiency of DPSCs isolated from exfoliated per-
manent teeth and the future clinical applications of DPSCs
remain an open question.
iPSCs provide a unique platform for the investigation of
disease mechanisms, drug discovery, and personalized treat-
ments.4 The accumulated research on this topic has demon-
strated that human iPSCs can be generated from human adult
cells via transfection with the transcription factors OCT4,
SOX2, KLF4, and c-Myc.1,2,23 Nevertheless, information
about the potential of DPC-reprogrammed iPSCs is still
lacking. The use of DPCs might bring advantages for iPSCs
reprogrammed over the use of other somatic cells as follows:
DPCs were reported to have a higher proliferation rate and
increase cell population doublings; DPCs are retrieved from a
tissue that is “disposable” and readily accessible in young
Fig. 4. Characterization of three-gene DPC-iPSC-Neus. (A) Multidimensional scaling and (B) average distance analysis show that the expression pattern of DPC-
iPSC-Neus was closer to the gene signature of ESC-Neus. Principal component analysis (PC1: vertical axis; PC2: horizontal axis; Unit: D-chip unit) is used to
measure the expression profiling using the bioinformatics methods. (C) Expression of neural-specific genes during the differentiation course of iPSC-Neus for 7
days, 14 days, and 21 days. Data shown here are the means ± standard deviation of three independent experiments. *p < 0.05 versus D0. Data shown here are
derived from permanent teeth, representatively. DPC-iPSC ¼ dental pulp cell-derived inducible pluripotent stem cell; DPC-iPSC-Neus ¼ DPC-iPSC-derived
neuron-like cells; ESC-Neus ¼ ESC-derived neuron-like cells; iPSC-Neus ¼ iPSC-derived neuron-like cells.
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studies proposed that dental pulp tissue containing stem cells
expresses elevated levels of pluripotent factors, is significantly
more efficient, and exhibits an accelerated generation of iPSCs
compared with conventional somatic cells.14,24 The first aim of
this study was to address whether deciduous and permanent
teeth can be used to generate human iPSCs. Using the three-
gene delivery method (OCT4/SOX2/KLF4), we successfully
created iPSCs by dedifferentiating DPCs isolated from the
clinical waste of donor teeth. Under a serum-free and feeder-
free cultured system, these iPSCs remained stable through 30
passages while retaining ESC-like pluripotency. The EBs
derived from these DPC-iPSCs could be differentiated into
neuroectodermal lineage neuron-like cells.
The major advantage of iPSCs over ESCs cells is that
iPSCs can be derived from a patient's own somatic cells,
thereby avoiding immune rejection after transplantation and
the ethical concerns regarding the use of ESCs. In addition, the
development of the technology for derivation of iPSCs from
human patients has opened up new pathways to the better
understanding of many human diseases, and has created new
opportunities for therapeutic approaches.1,2 Among the four
factors (OCT4, SOX2, KLF4, and c-Myc) for conventionaliPSCs reprogramming, the pro-oncogene c-Myc plays a crit-
ical role in influencing reprogramming efficiency.12 However,
a previous report suggests that the deregulated expression of c-
Myc occurs in a wide range of human cancers, is often asso-
ciated with poor prognosis, and may contribute to tumori-
genesis by overstimulating cell growth and metabolism and/or
by causing genomic instability.12,25 Therefore, c-Myc might
be a major obstacle in iPSC-based cell transplantation because
of its tumorigenetic propensity and terotoma formation
in vivo.26 To eliminate teratoma formation, some alternative
experimental approaches have been used in several studies. In
one of our recent studies, we have shown that the oncogene c-
Myc was expected to substantially contribute to tumor for-
mation in Acute hepatic failure (AHF) recipients, but the
tumor formation could be prevented in the livers of mice that
received three-gene iPSCs and three-gene iPSC-Heps 6
months after transplantation.11 In this study, three-gene iPSCs
from DPCs were positive for OCT4, SSEA-1 (ESC markers),
and alkaline phosphatase, were not affected by passage num-
ber, and were identical to that of four-gene iPSC colonies.
Furthermore, the microarray gene expression between three-
gene IPSCs, four-gene iPSCs, and ESCs were similar, and
the three-gene iPSC-derived embryonic bodies could also be
625Y.-C. Chang et al. / Journal of the Chinese Medical Association 77 (2014) 618e625differentiated into neuroectodermal lineage neuron-like cells.
This molecular and differentiation evidence implies the niche
of three-gene iPCs in future cell therapy. iPSCs without c-
Myc, especially under differentiated states, represents a more
feasible cell source for iPSC-based replacement therapy and
in vitro screening.
Because viral integration into the host genome has been
demonstrated to possibly increase the risk of tumorigenicity,
the production of virus-free iPSCs addresses a critical safety
concern for the potential use of iPSCs in regenerative med-
icine.27 A large part of the tooth, including the dental pulp, is
derived from the neural crestdthe same neural crest that
forms neurons during development.28 Thus, DPCs and
DPSCs are possibly more prone to forming neurons than
other stem cells. Direct reprogramming of DPCs into neural
combined with nonviral vector delivery should be encour-
aged in future studies. In conclusion, this study showed that
with the iPSC-based technology, surgical residues usually
regarded as medical waste such as DPCs can be used as an
alternative source of pluripotent stem cells for personalized
medicine.
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